CRIS Q4 2021 Earnings — Curis, Inc. Revenue & Financial Results | Market Cap Arena

CRISCuris, Inc.

$15M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+3.7% YoY

Gross Profit

$3M95.0% margin

Operating Income

-$13M-400.9% margin

Net Income

-$14M-434.4% margin

EPS (Diluted)

$-2.97

QoQ Revenue Growth

+3.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$162M

Total Liabilities

$72M

Stockholders' Equity

$91M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+3.7%
Gross Profit	$3M	$3M	+3.7%
Operating Income	-$13M	-$6M	-100.3%
Net Income	-$14M	-$8M	-81.2%

Revenue Segments

Gross Royalty Revenue

$3M100%